CC Bio - Crunchbase Company Profile & Funding

Start Free Trial

Overview

CC Bio

Growth Score

78

Heat Score

40

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About CC Bio

CB Rank

361578

CC Bio develops therapeutic discovery methodologies that target microbiome-based diseases for diagnosis and treatment.

Acquired by

Precisio Biotix Therapeutics

Founded

obfuscation

Private

London, England, United Kingdom

www.ccbio.co.uk/

Key People

Matthew Cummings: Co-Founder and Chief Executive Officer
Past Role: Innovation Forum, Business Development Associate
David Corcoran: Co-Founder and COO
Past Role: Deep Science Ventures, Cohort Member

Details

Legal Name

CC Bio, Ltd.

Operating Status

Active

Company Type

For Profit

Founders

David Corcoran, Matthew Cummings

About the Company

CC Bio develops therapeutic discovery methodologies that target microbiome-based diseases for diagnosis and treatment.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Zeus

A proprietary drug discovery platform that evaluates and optimizes thousands of therapeutic candidates for microbiome modulation.

CCB2.1 Therapeutic Candidate

A preclinical drug candidate targeting recurrent bacterial vaginosis by disrupting Gardnerella vaginalis biofilms to reduce infection recurrence.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

was acquired by

Precisio Biotix Therapeutics

on

obfuscation

.

Transaction Name

CC Bio acquired by Precisio Biotix Therapeutics

Acquired by

Precisio Biotix Therapeutics

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

Employee Profiles

Contacts

Employee Profiles

Matthew Cummings Co-Founder and Chief Executive Officer
David Corcoran Co-Founder and COO

News

News and Press

News•

Mar 6, 2024

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Mar 1, 2024

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Access a complete feed of recent news and press, from product launches to leadership changes.

Technology

View Tech Report

Monthly Web Visits

198

4.21%

in past month

IT Spend

$173.7K

This year,

is projected to spend

on IT, according to Aberdeen.

Active Website Tech Count

20

is actively using

20

technologies for its website, according to BuiltWith. These include

,

, and

Apple Mobile Web Clips Icon

.

Lists Featuring This Company

Lists Featuring This Company

Europe Acquired Companies With Fewer Than 10 Employees

4,288 Number of Organizations • $10.6B Total Funding Amount • 2,122 Number of Investors

London Acquired Companies

3,742 Number of Organizations • $125.5B Total Funding Amount • 4,010 Number of Investors

England Acquired Companies With Fewer Than 1000 Employees

2,809 Number of Organizations • $56.4B Total Funding Amount • 3,670 Number of Investors

Acquired England Companies

6,056 Number of Organizations • $148.5B Total Funding Amount • 6,343 Number of Investors

Sub-Organizations

Frequently Asked Questions

Where is

's headquarters?

is located in

London, England, United Kingdom

.

Who are

's competitors? Alternatives and possible competitors to

may include

,

, and

.